DIA2015The 51st Annual DIA 2015, the largest global multidisciplinary event for professionals in the discovery, development and life cycle management of pharmaceuticals, biotechnology, medical devices, and related products is less than a week away.

DIA 2015 takes place from Sunday, June 14, to Thursday, June 18, 2015 at the Walter E. Washington Convention Center, Washington, DC. The conference is always an excellent opportunity to learn what the industry is doing and how progress is being made, and this year is definitely no exception.

It’s no surprise that risk-based monitoring has many sessions devoted to it this year. Additionally, patient-centered trials and clinical innovation also merit their level of representation. In anticipation of DIA 2015, Paragon Solutions shares an update on some of the 'must see' sessions!

risk.management.goals-2Risk-Based Monitoring

Monday, June 15

Tuesday, June 16

  • 8:00 - Session #209 - Implementing Risk-Based Monitoring with Willie MuehlhausenRoland Rich, Tammy Finnigan, and Erik Doffagne
  • 10:30 - Session #238 - Risk-Based Quality Management in Clinical Trials: From the Vision to Its Regulation and Implementation with Anabela Marcal, Ni A. Khin, and Stephanie Shapley
  • 1:30 - Session 252 - Implementing Risk-Based Monitoring: Best Practices from Pharmaceutical Industries to Contract Research Organizations with Warren H. Pence, Mary Arnould, and Peggy Zavala
  • 3:30 - Session 277 - How Risk-Based Monitoring and eSource Methodologies are Impacting Clinical Sites, Patients, Regulators and Sponsors with Jules Mitchel, Frances NolanAvik Kumar Pal, and Edward Seguine

Wednesday, June 17

Thursday, June 18

  • 10:45 - Session 413 - DEVELOP Risk-Based Monitoring Strategies to INNOVATE Study Oversight and ADVANCE Study Execution with Lynn King 


Collaborating with Patients & Patient-Centric Trials

Tuesday, June 16

Innovating Clinical Trials
(Process & Technology)

Tuesday, June 16

Wednesday, June 17

Thursday, June 18

  • 9:00 - Session 405 - Tired of Reinvesting in Old R&D Systems? Several Large Pharmaceutical Companies and Other Leaders Are Flipping Paradigms with Jonathan Burr and Sandra Tremps.


Paragon’s Michael Agard, Principal Consultant, will present ‘Think Standard Inventory Means Technical Interoperability? Think Again’ during DIA 2015’s session, ‘Mapping the Future for Trial Master File: Advancing Standards by Harmonizing Clinical and Technical Strengths’ beginning at 8 a.m. on Wednesday, June 17, in Room 202B of the Walter E. Washington Convention Center.

What To Expect?

To get ready for DIA 2015, review Information Governance in Clinical Trials: What You Need to Know and Risk-Based Monitoring: 3 Reasons RBM Is Not Widespread - Yet.

See You There!

Paragon's Life Sciences R&D team will feature solutions to help Sponsors and CROs increase operational efficiency, lower costs, improve situational awareness and manage risk.These solutions aim to drive a high-performing organization across strategy, people, processes, information and technology. If you are attending the conference, be sure to stop by Paragon Solutions Booth 2204 and say hello to Paragon’s R&D team!